The Concomitant Use of Angiotensin System Inhibitors Predicts Favorable Prognosis for Renal Cell Carcinoma Patients
Crossref DOI link: https://doi.org/10.32948/auo.2025.08.18
Published Online: 2025-08-28
Published Print: 2025-08-28
Update policy: https://doi.org/10.32948/asme.crossmark.policy
Hu, Shuenqin
Li, Xiuying
Publication History
Received: 2025-8-3
Accepted: 2025-8-18
Published Online: 2025-8-28
